The health care reform plan that narrowly passed the House Saturday would hit home-health companies such as Amedisys, an analyst told Bloomberg News. Paul Heldman with the Potomac Research Group in Washington, D.C., says the plan would lead to more than $50 billion in cuts to the growth of Medicaid reimbursement over the next 10 years. Shares of Baton Rouge-based Amedisys were up slightly in early trading, up 40 cents to $40.36.
Health care reform would hit Amedisys
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
